Project description
Innovative technology for high-throughput microbiome profiling
The thousands of species of the human gut microbiome have been linked to different diseases from cancer to diabetes. Current analytics methods are too inefficient for microbiome tracking throughout disease states, or to establish correlations with disease progression and enable personalised treatment. The EU-funded Perseus MAP project will support Perseus Biomics from Belgium in developing a unique microbiome analytics platform to satisfy the growing demand for more efficient techniques. The development is based on a fast, high-throughput, highly accurate proprietary DNA imaging technology. Introduction of this technology will accelerate microbiomics, creating a network of laboratories and producing portable units for the microbiomics mass market.
Objective
The thousands of microbial species that compose the human gut microbiome are linked to diseases from cancer to diabetes, sparking tremendous interest among pharmaceutical/ medical researchers in microbiome analytics. Current analytics methods are far too slow, expensive, and inaccurate to fulfil this need. Much faster techniques are essential for microbiome tracking over the course of disease states and therapies to discover correlations with disease and enable personalized medicine. Perseus MAP is the only microbiome analytics platform that will be able to handle this onslaught of demand, through a revolutionarily fast, high-throughput, and accurate technology based on DNA imaging techniques invented in the lab of our co-founders. We will massively accelerate microbiomics, starting with a central service lab, deploying satellite labs, and finally producing portable units for the microbiomics mass market, at a capacity of 300k profiles/yr analyzed in-house to seize a €2.5B market.
Fields of science
- engineering and technologymechanical engineeringvehicle engineeringaerospace engineeringsatellite technology
- medical and health sciencesclinical medicineendocrinologydiabetes
- medical and health sciencesclinical medicineoncology
- medical and health scienceshealth sciencespersonalized medicine
- natural sciencesbiological sciencesmicrobiology
Programme(s)
Funding Scheme
HORIZON-AG - HORIZON Action Grant Budget-BasedCoordinator
3300 Tienen
Belgium
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.